PMID- 14984928 OWN - NLM STAT- MEDLINE DCOM- 20040604 LR - 20220311 IS - 0006-3002 (Print) IS - 0006-3002 (Linking) VI - 1676 IP - 3 DP - 2004 Feb 20 TI - Efficient transfer of chromosome-based DNA constructs into mammalian cells. PG - 223-30 AB - Artificial chromosomes, engineered minichromosomes and other chromosome-based DNA constructs are promising new vectors for use in gene therapy, protein production and transgenics. However, a major drawback in the application of chromosome-based DNA is the lack of a suitable and convenient procedure for large-scale cellular introduction, which is particularly frustrated by their size (1 by 2 microm). Here we present a method to transfer Artificial Chromosome Expression systems (ACEs) into mammalian cells, which relies on a combined approach of using cationic amphiphiles and high frequency ultrasound. Thus, when cells were preincubated with liposomes consisting of the cationic lipid SAINT-2 and the phospholipid dioleoylphosphatidylethanolamine (molar ratio 1:1), followed by ultrasound, ACEs could be introduced into mammalian cells, which resulted in the expression of ACEs-harbored reporter genes, such as Green Fluorescent Protein. Depending on cell type, transfection efficiencies ranged from 12% to 53%. Interestingly, no detectable delivery occurred when cells were treated alone with either ultrasound or liposomes. Evidence is provided, based on cellular entry of differently sized beads and trypan-blue permeation, which supports a mechanism in which integration of the lipids creates unstable membrane domains, which are particularly prone to ultrasound-induced pore formation. Time- and temperature-dependent experiments indicate that these pores display a transient stability. Hence, following ultrasound, the pores disappear as a function of time as suggested by a time-window for ACEs entry, and trypan blue exclusion, 80% of the cells becoming stained immediately following ultrasound, dropping to approximately 20% after 30 min. Co-expression of different genes in conjunction with fluorescence in situ hybridization (FISH) analysis indicates that the current procedure provides a means to introduce functionally active artificial chromosomes into eukaryotic cells. FAU - Oberle, Volker AU - Oberle V AD - Department of Membrane Cell Biology, Faculty of Medical Sciences, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. FAU - de Jong, Gary AU - de Jong G FAU - Drayer, Jan I AU - Drayer JI FAU - Hoekstra, Dick AU - Hoekstra D LA - eng PT - Journal Article PL - Netherlands TA - Biochim Biophys Acta JT - Biochimica et biophysica acta JID - 0217513 RN - 0 (1,2-dioleoyl-glycero-3-phosphatidyl ethanolamine) RN - 0 (Hanks Balanced Salt Solution) RN - 0 (Isotonic Solutions) RN - 0 (Phosphatidylethanolamines) RN - 0 (Pyridinium Compounds) RN - 0 (SAINT 2) SB - IM MH - Animals MH - Cells, Cultured MH - *Chromosomes, Artificial MH - Genetic Therapy/methods MH - Genetic Vectors/*pharmacology MH - Humans MH - In Situ Hybridization, Fluorescence MH - Isotonic Solutions MH - Particle Size MH - Phosphatidylethanolamines MH - Pyridinium Compounds MH - Temperature MH - Time Factors MH - Transfection/*methods MH - Ultrasonics EDAT- 2004/02/27 05:00 MHDA- 2004/06/05 05:00 CRDT- 2004/02/27 05:00 PHST- 2003/07/02 00:00 [received] PHST- 2003/12/15 00:00 [revised] PHST- 2003/12/15 00:00 [accepted] PHST- 2004/02/27 05:00 [pubmed] PHST- 2004/06/05 05:00 [medline] PHST- 2004/02/27 05:00 [entrez] AID - S0167478103002896 [pii] AID - 10.1016/j.bbaexp.2003.12.003 [doi] PST - ppublish SO - Biochim Biophys Acta. 2004 Feb 20;1676(3):223-30. doi: 10.1016/j.bbaexp.2003.12.003.